Reckitt Benckiser Group plc

5,590pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:RKTConsumer Staples
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR 0.60%
Div yield 3.80%
ROE 48.02%
Household & Personal Products
Beta (5Y) 0.29
PE TTM 12.62
TSR TTM 1.13%
Mkt cap £35.50B
ROIC 16.93%
SE Grade™
Value
Quality
Moat
Consensus
Reference
6,491p
16.12%
(92.97%)
Hold 11|6|11|9|4
4Q25
1Q26
2Q26
3Q26
Earnings per share£
77.10
82.20
88.06
89.98
3.36%
7.91%
20.80%
16.09%
Revenue£B
3.046
3.195
3.382
3.380
(2.27%)
2.52%
10.76%
13.25%
Peers (US$47.77B)
Cap (US$)
PE
142.8B
13.54x
56.34B
32.06x
50.00B
31.18x
Capital
TTM
5Y
10Y
Leveragex
0.131
(0.333)
(0.272)
EBIT/Intx
0.967
0.114
0.146
Own earn%
(96.63)
8.67
8.93
Sh yield%
54.63
10.74
11.58
Owners
Insiders/Inst%
1.21
37.35
Short interest%
3.05
SBC / revenue%
1.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
0–3
$1 testx
—
Incr. ROIC%
2

Reckitt Benckiser Group plc manufactures and sells health, hygiene and nutrition products in the United Kingdom and internationally, including Dettol germ protection, Durex and KY intimate wellness, over-the-counter Nurofen, Gaviscon and Mucinex, Clearasil and Veet personal care, MegaRed and Airborne supplements, Vanish stain removal, Finish, Harpic and Lysol disinfectants, and Enfamil and Nutramigen infant nutrition.